Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV- resistant prostitutes in Nairobi

Journal of Clinical Investigation

Volumn 102, Issue 9, 1998, Pages 1758-1765

  Rowland Jones, Sarah L ^a   Dong, Tao ^a   Fowke, Keith R ^b   Kimani, Joshua ^c   Krausa, Pete ^a   Newell, Heidi ^a   Blanchard, Tom ^a   Ariyoshi, Koya ^d   Oyugi, Julius ^c   Ngugi, Elizabeth ^c   Bwayo, Job ^c   MacDonald, Kelly S ^c,e   McMichael, Andrew J ^a   Plummer, Francis A ^b,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d MRC Unit   (Gambia)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

AIDS in Africa; Cross clade immune responses; Human immunodeficiency virus specific cytotoxic T lymphocytes

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; KENYA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTITUTION; VIRUS RESISTANCE;

EID: 18344418801     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4314     Document Type: Article

References (42)

1. Clerici, M., and G. Shearer. 1993. A Th1→Th2 switch is a critical step in the aetiology of HIV infection. Immunol. Today. 14:107-111.
2. Rowland-Jones. S.L., and A.J. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448-455.
3. Mazzoli, S., D. Trabbatoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250-1257.
4. Rowland-Jones. S.L., J. Sutton, K. Ariyoshi, T. Dong, F.M. Gotch, S. McAdam, D. Whithy, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
5. Moses, S., F.A. Plummer, E.N. Ngugi, N.J. Nagelkerke, A.O. Anzala, and J.O. Ndinya-Achola. 1991. Controlling HIV in Africa: effectiveness and cost of an intervention in a high frequency STD transmitter core group. AIDS. 5:407-411.
6. Anzala, O.A., N.J. Nagelkerke, J.J. Bwayo, D. Holton, S. Moses, E.N. Ngugi, J.O. Ndinya-Achola, and F.A. Plummer. 1995. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J. Infect. Dis. 171:686-689.
7. Anzala, A.O., T.B. Ball, T. Rostron, S.J. O'Brien, F.A. Plummer, the Nairobi HIV study group, and S.L. Rowland-Jones. 1998. The 64I allele of the CCR2 chemokine receptor is strongly associated with delayed disease progression in a cohort of African prostitutes. Lancet. 351:1632-1633.
8. Fowke, K., N. Nagelkerke, J. Kimani, J.N. Simonsen, A.O. Anzala, J.J. Bwayo, K.S. MacDonald, E.N. Ngugi, and F.A. Plummer. 1996. Resistance to HIV-1 infection amongst persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 348:1347-1351.
9. Ferrari, G., W. Humphrey, M.J. McElrath, J.L. Excler, A.M. Duliege, M.L. Clements, L.C. Corey, D.P. Bolognesi, and K.J. Weinhold. 1997. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA. 94:1396-1401.
10. Cao, H., P. Kanki, J.L. Sankale, S.A. Dieng, G.P. Mazzara, S.A. Kalams, B. Korber, S. Mboup, and B.D. Walker. 1997. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol. 71:8615-8623.
11. Betts, M.R., J. Krowka, C. Santamaria, K. Balsamo, F. Gao, G. Mulundu, C. Luo, N. N'Gandu, H. Sheppard, B.H. Hahn, et al. 1997. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J. Virol. 71:8908-8911.
12. McAdam, S., P. Kaleebu, P. Krausa, P. Goulder, N. ,French, B. Collin, T. Blanchard, J. Whitworth, A. McMichael, and F.M. Gotch. 1998. Cross-clade recognition of p55 by CTL in HIV-1 infection. AIDS. 12:571-579.
13. Korber, B., J. Moore, C. Brander, B. Walker, B. Haynes, and R. Koup. 1997. HIV Molecular Immunology Database. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
14. Poss, M., J. Gosink, E. Thomas, J.K. Kreiss, J. Ndinya-Achola, K. Mandaliya, J. Bwayo, and J. Overbaugh. 1997. Phylogenetic evaluation of Kenyan HIV type 1 isolates. AIDS Res. Hum. Retroviruses. 13:493-499.
15. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlman, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell. 88:7-20.
16. Paxton, W.A., S.R. Martin, D. Tse, T.R. O'Brien, J. Skurnick, N.L. Van Devanter, N. Padian, J.F. Braun, D.P. Kotler, S.M. Wolinsky, et al. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-rish sexual exposures. Nat. Med. 2:412-417.
17. Huang, Y., W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
18. Michael, N.L., G. Chang, L. Louie, J.R. Mascola, D. Dondero, D.L. Birx, and H.W. Sheppard. 1997. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3:338-340.
19. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273:1856-1862.
20. Martinson, J.J., N.H. Chapman, D.C. Rees, Y.-T. Liu, and J.B. Clegg. 1997. Global distribution of the CCR5 gene 32 base-pair deletion. Nat. Genet. 16:100-103.
21. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.-M. Farber, S. Saragosti, C. Lapumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:722-725.
22. Fowke, K., T. Dong, S.L. Rowland-Jones, J. Oyugi, W.J. Rutherford, P. Krausa, J. Kimani, J. Bwayo, J.N. Simonsen, G. Shearer, et al. 1998. HIV-1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV-1 infection or enhanced beta-chemokine production. AIDS Res. Hum. Retroviruses. 14:1521-1530.
23. Bunce, M., C.M. O'Neill, M.C. Barnardo, P. Krausa, M.J. Browning, P.J. Morris, and K.I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers. Tissue Antigens. 46:355-367.
24. Barouch, D., T. Friede, S. Stevanovic, L. Tussey, K. Smith, J.S. Rowland, V. Braud, A. McMichael, and H.G. Rammensee. 1995. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182: 1847-1856.
25. Nixon, D.F., A.R.M. Townsend, J.G. Elvin, C.R. Rizza, J. Gallwey, and A.J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336:484-487.
26. Lalvani, A., T. Dong, G. Ogg, A.A. Patham, H. Newell, A.V. Hill, A.J. McMichael, and S. Rowland-Jones. 1997. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods. 210:65-77.
27. Lalvani, A., R. Brookes, S. Hambleton, W.J. Britton, A.V. Hill, and A.J. McMichael. 1997. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:859-865.
28. Lalvani, A., R. Brookes, R.J. Wilkinson, A.S. Malin, A.A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A.V. Hill. 1998. Human cytolytic and interferon gamma-secreting CDS+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 95:270-275.
29. Ogg, G.S., T. Dong, P. Hansasuta, L. Dorrell, J. Clarke, R. Coker, G. Luzzi, C. Conlon, A.J. McMichael, and S.L. Rowland-Jones. 1998. Four novel CTL epitopes in the highly-conserved MHR region of HIV-1 gag, restricted by B*4402, B*1401, A*2601 and B*70. AIDS. 12:1561-1563.
30. Phillips, R.E., S.L. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Rothbard, C.R. Bangham, C.R. Rizza, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:453-459.
31. Pinto, L.A., J. Sullivan, J.A. Berzofsky, M. Clerici, H.A. Kessler, A.L. Landay, and G.M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867-876.
32. Rowland-Jones, S.L., D.F. Nixon, M.C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J.S. Kroll, K. Froebel, and A.J. McMichael. 1993. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet. 341:860-861.
33. Mammano, F., A. Ohagen, S. Hoglund, and H.G. Gottlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-4936.
34. Threlkeld, S.C., P.A. Wentworth, S.A. Kalams, B.M. Wilkes, D.J. Ruhl, E. Keogh, J. Sidney, S. Southwood, B.D. Walker, and A. Sette. 1997. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J. Immunol. 159:1648-1657.
35. del Guercio, M.-F., J. Sidney, G. Hermanson, C. Perez, H.M. Grey, R.T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685-693.
36. Bertoni, R., J. Sidney, P. Fowler, R.W. Chesnut, F.V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503-513.
37. Khanna, R., S.R. Burrows, J. Nicholls, and L.M. Poulsen. 1998. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28:451-458.
38. Shearer, G.M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today. 17:21-24.
39. Zhang, C., Y. Cui, S. Houston, and L.J. Chang. 1996. Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. Proc. Natl. Acad. Sci. USA. 93: 14720-14725.
40. Putkonen, P., B. Makitalo, D. Bottiger, G. Biberfeld, and R. Thorstensson. 1997. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J. Virol. 71:4981-4984.
41. Quillem, C., E. Oberlin, J. Braun, D. Roussel, G. Gonzalez-Canali, P. Metais, L. Montagnier, J.-L. Virelizier, F. Arenzana-Seisdedos, and A. Beretta. 1997. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet. 351:14-18.
42. Ada, G.L., and M.J. McElrath. 1997. HIV-1 vaccine-induced cytotoxic T-cell responses: potential role in vaccine efficacy. AIDS Res. Hum. Retroviruses. 13:205-210.